ISSN: 1746-0441

Journal Home

Journal Guideline

Expert Opinion on Drug Discovery Q1 Unclaimed

Informa Healthcare United Kingdom

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Expert Opinion on Drug Discovery is a journal indexed in SJR in Drug Discovery with an H index of 84. It has an SJR impact factor of 1,077 and it has a best quartile of Q1. It has an SJR impact factor of 1,077.

Expert Opinion on Drug Discovery focuses its scope in these topics and keywords: drug, preclinical, discovery, rna, treatment, tool, target, sclerosis, scaffold, schizophrenia, ...

Type: Journal

Type of Copyright:

Languages:

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Drug Discovery (Q1)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

1,077

SJR Impact factor

84

H Index

108

Total Docs (Last Year)

345

Total Docs (3 years)

10997

Total Refs

1947

Total Cites (3 years)

285

Citable Docs (3 years)

5.6

Cites/Doc (2 years)

101.82

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Protein & Cell Q1
Molecular Therapy Q1
Nature Reviews Drug Discovery Q1
Medicinal Research Reviews Q1
Cell Chemical Biology Q1

Compare this journals

Aims and Scope

Best articles by citations

The development of biological therapies for neurological diseases: moving on from previous failures

Advances in omics for informed pharmaceutical research and development in the era of systems medicine

Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal

Computational methods to support high-content screening: from compound selection and data analysis to postulating target hypotheses

Fragment screening by biochemical assay

Metabolomic tools used in marine natural product drug discovery

Next generation histone deacetylase inhibitors: the answer to the search for optimized epigenetic therapies?

Identification of protein binding partners of small molecules using label-free methods

An overview of molecular fingerprint similarity search in virtual screening

In vitro prediction of brain penetration -a case for free thinking?

Therapeutic strategies against protein misfolding in neurodegenerative diseases

Thoughts on the progression of type 2 diabetes drug discovery

SHOW MORE ARTICLES

Computational approaches in chemogenomics and chemical biology: current and future impact on drug discovery

The ideal model in atherosclerosis and dyslipidaemia -does it exist?

Modulators of calpain activity: inhibitors and activators as potential drugs

In silico frameworks for systematic pre-clinical screening of potential anti-leukemia therapeutics

Development of drugs for Epstein-Barr virus using high-throughputin silicovirtual screening

Future trends in screening technology for drug discovery

Invertebrate and fungal model organisms: emerging platforms for drug discovery

The successes and failures of HIV drug discovery

Third-generation sequencing techniques and applications to drug discovery

Identifying and testing potential new anti-asthma agents

Perspective on the drug discovery and market landscape in Japan: can it compete in the worldwide arena?

The discovery and development of perampanel for the treatment of epilepsy